| |
|
|
|
Alpine Immune Sciences Inc.  
|
|
4.83 -0.03 (-0.01%) |
12-13 16:00 |
|
Open: |
5.02 |
Pre close: |
4.86 |
Target:
|
5.84
|
|
High: |
4.93 |
Low: |
4.7738 |
Resistance:
|
5.00
5.30
|
|
Volume: |
10,155 |
Market Cap: |
67M |
Support:
|
4.51
3.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.82
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
4.88  |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
5.81 |
Stochastic Oscillator |
%K(14,3):
|
46.62 |
|
MA(250): |
7.78 |
%D(3): |
43.74 |
|
Average Volume(K) |
3-Month: |
1590
|
52-Week |
High:
|
11.74 |
|
10-Days: |
1814 |
Low: |
4.51 |
|
RSI |
RSI(14):
|
45.97 |
Change(%): |
-56.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.160 |
Return on Equity (ttm) |
-43.0 |
Shares Out. (M) |
13.85 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-38.2 |
Shares Float (M) |
13.68 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.30 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
44.00 |
|
Forward EPS |
-2.604 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.210 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.24 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.99 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-24.86 |
P/S |
1114925056.00 |
|
Operating Margin |
-3573.95 |
Levered Free Cash Flow
(M) |
-14.49 |
P/CF |
-2.69 |
|
|
|
|
|
|
